Globus Medical Inc (GMED) Narxning foydaga nisbati

Globus Medical Inc (GMED) korporativ emblemasi va logotipi

Tashqi komponent yetkazib beruvchilarga bo'lgan bog'liqlik qat'iy yig'ish protokoli orqali yumshatiladi, buni Globus Medical, Inc. (GMED) uchun P/E koeffitsiyentining o'zgarishi isbotlaydi, bunda ko'rsatkich 13.90 atrofida qolmoqda. Barqarorlik kompaniyaning umurtqa pog'onasi jarrohligi robototexnikasini ishlab chiqishdagi yetakchiligi bilan ta'minlanmoqda. Shu bilan birga, shifokorlar sadoqati uchun kurash va startaplarning texnologik gigantlar tomonidan sotib olinish xavfi Globus Medical, Inc. (GMED) ni doimiy ravishda noyob implantlarga investitsiya kiritishga majbur qilmoqda.

NuVasive (GMED) Narx-foyda koeffitsiyenti: 04.07.2022 - 18.11.2026 davri uchun

Globus Medical (GMED) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning umumiy tahlili:Globus Medical Inc - GMED
globusmedical.com original mahsuloti

P/E koeffitsiyenti bozor kapitalizatsiyasi va sof foyda o'rtasidagi bog'liqlik orqali biznes qiymatini aks ettirib, bozor narxining operatsion samaradorlik va xarajatlarga sezgirligini ko'rsatadi. Yuqori marjali robototexnika va jarrohlar sodiqligi tufayli barqaror pul oqimi Globus Medical, Inc. (GMED) kompaniyasini tebranishlarga chidamli qiladi, bu esa uzoq muddatli o'rtacha ko'rsatkichlardan pastroq narxda kirish nuqtalarini aniqlash uchun P/E baholashidan foydalanish imkonini beradi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|TMDX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati ATEC Spine (ATEC)|AORT (Artivion) - P/E multiplikatori|Narx-foyda multiplikatori ENOV (Enovis)|Narx-foyda koeffitsiyenti IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati iLet Bionic Pancreas BBNX|IRMD - Narx-foyda koeffitsiyenti|Embecta Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tandem Diabetes Care|AXGN: P/E multiplikatori|Narx-foyda multiplikatori SIBN|OFIX (Orthofix Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti Bioventus Corp (BVS)|P/E multiplikatori KIDS|Narx-foyda koeffitsiyenti Treace Medical Concepts TMCI|P/E multiplikatori SRTA (blade.com)|P/E multiplikatori Carlsmed, Inc. CARL|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis, Inc.) - Narx-foyda koeffitsiyenti|Neuronetics, Inc. - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Orchestra BioMed Inc. OBIO|Narxning foydaga nisbati Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical International Ltd. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)